Curitics Taps Health Policy Veteran John Gorman to Push Tech and Equity Work Forward

Curitics names John Gorman executive advisor to drive tech innovation and health-equity efforts

Curitics Health Solutions announced on December 15 that it has appointed John Gorman as an executive advisor. The company said Gorman will help accelerate its technology development and expand its health-equity initiatives, working with product teams, clinical partners and external stakeholders. Curitics provides clinical-decision tools and workflow software used by hospitals and physician groups, and the hire signals a push to translate those tools into wider adoption and measurable equity gains.

The appointment is explicitly framed as a bridge role: Gorman will connect Curitics’ engineers and data scientists with frontline clinicians and payer organizations, and advise on how to shape tools so they fit real-world care settings. The company expects his input to influence product priorities, partnership strategy and how Curitics measures the social impact of its work.

What John Gorman brings: a long career across policy, partnerships and health programs

John Gorman is a well-known figure in U.S. health circles. Over several decades he has worked at the intersection of health policy, payer-provider relationships and program design. His career includes leadership roles in nonprofits, advisory work with public agencies, and help steering collaborations that tie clinical practice to payment and quality goals.

That mix — policy fluency, experience building multi-stakeholder partnerships, and a history of program work aimed at improving access and outcomes — is precisely what Curitics highlighted in explaining the hire. The company says Gorman’s experience will help its team think beyond feature development to questions of measurement, financing and how tools perform across different patient populations.

Why Curitics made the move now: timing, priorities and the problem it wants to solve

Curitics is moving at a time when health systems want tech that fits into clinician workflows and also shows clear benefits for equity and cost. The market has shifted from curiosity about new tools to scrutiny of whether those tools actually change care and outcomes. Curitics’ decision to add an advisor with a background in partnerships and policy suggests the company wants to meet that test.

Specifically, Curitics appears to be aiming for three things. First, faster translation of prototypes into hospital pilots and payer-supported deployments. Second, clearer ways to track whether tools reduce disparities — for example by improving care for patients who historically receive lower-quality treatment. And third, partnerships that bring in payment or support from payers and health systems to scale successful pilots. Gorman’s role is meant to shorten the path from product idea to measurable, funded use in practice.

How this hire could change Curitics’ products and day-to-day work for clinicians

Expect practical shifts rather than flashy new features. Under Gorman’s guidance, Curitics may prioritize usability and integration into existing electronic workflows so clinicians can adopt tools with minimal disruption. That typically means simpler interfaces, clearer clinician prompts, and fewer clicks to act on recommendations.

On the data side, Curitics is likely to focus on building the kinds of performance reports that hospitals and payers need to justify broader adoption: metrics that show where care improved, who benefited, and how costs changed. That kind of reporting can unlock funded pilots or value-based contracts. For front-line clinicians, the end result could be more tailored decision support that flags high-risk patients and includes context about social or access barriers — if Curitics follows through on its equity promises.

Where this fits in the broader health-tech picture and what to watch next

Across health tech, leaders are increasingly judged by impact, not just innovation. Companies that can show improved outcomes and reduced disparities have a clearer path to scale. Curitics’ hire fits that trend: it signals a move from technology-building to implementation and measurement.

Over the coming months, watch for a few concrete signs that Gorman’s appointment is more than symbolic. Those include announced partnerships with health systems or payers, new pilot studies with published outcome measures, revised product releases that emphasize workflow fit, and public reporting on equity-focused metrics. If Curitics can align its tools with financing and measurement, the company may find a faster route from small pilots to broader use.

For now, the addition of an experienced advisor gives Curitics a clearer playbook: make tools clinicians want to use, prove they help patients fairly, and secure the partnerships that pay for wider rollouts. The real test will be whether those plans turn into measurable improvements in care and access.

Sources

• prnewswire.com